Walters Group

Zentalis Pharmaceuticals, Inc. · 10% Owner

Walters Group is listed in public filings as 10 percent owner. This Walters Group insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Zentalis Pharmaceuticals, Inc. (ZNTL). Investors use Walters Group's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Zentalis Pharmaceuticals, Inc.ZNTL$7.8M6.5M sharesBuyDec 31, 2025$1.20--